Yael David - Publications

mskcc, New York, NY, United States 

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Maksimovic I, Finkin-Groner E, Fukase Y, Zheng Q, Sun S, Michino M, Huggins DJ, Myers RW, David Y. Deglycase-activity oriented screening to identify DJ-1 inhibitors. Rsc Medicinal Chemistry. 12: 1232-1238. PMID 34355187 DOI: 10.1039/d1md00062d  1
2021 Wu A, Zhi J, Tian T, Cihan A, Cevher MA, Liu Z, David Y, Muir TW, Roeder RG, Yu M. DOT1L complex regulates transcriptional initiation in human erythroleukemic cells. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34187895 DOI: 10.1073/pnas.2106148118  1
2021 Faulkner S, Maksimovic I, David Y. A chemical field guide to histone nonenzymatic modifications. Current Opinion in Chemical Biology. 63: 180-187. PMID 34157651 DOI: 10.1016/j.cbpa.2021.05.002  1
2021 Maksimovic I, David Y. Non-enzymatic Covalent Modifications as a New Chapter in the Histone Code. Trends in Biochemical Sciences. PMID 33965314 DOI: 10.1016/j.tibs.2021.04.004  1
2020 Willcockson MA, Healton SE, Weiss CN, Bartholdy BA, Botbol Y, Mishra LN, Sidhwani DS, Wilson TJ, Pinto HB, Maron MI, Skalina KA, Toro LN, Zhao J, Lee CH, Hou H, ... ... David Y, et al. H1 histones control the epigenetic landscape by local chromatin compaction. Nature. PMID 33299182 DOI: 10.1038/s41586-020-3032-z  1
2020 Yusufova N, Kloetgen A, Teater M, Osunsade A, Camarillo JM, Chin CR, Doane AS, Venters BJ, Portillo-Ledesma S, Conway J, Phillip JM, Elemento O, Scott DW, Béguelin W, Licht JD, ... ... David Y, et al. Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture. Nature. PMID 33299181 DOI: 10.1038/s41586-020-3017-y  1
2020 Zheng Q, Osunsade A, David Y. Protein arginine deiminase 4 antagonizes methylglyoxal-induced histone glycation. Nature Communications. 11: 3241. PMID 32591537 DOI: 10.1038/S41467-020-17066-Y  1
2020 Maksimovic I, Zheng Q, Trujillo MN, Galligan JJ, David Y. An Azidoribose Probe to Track Ketoamine Adducts in Histone Ribose Glycation. Journal of the American Chemical Society. PMID 32390412 DOI: 10.1021/Jacs.0C01325  1
2020 Zheng Q, Maksimovic I, Upad A, David Y. Non-enzymatic covalent modifications: a new link between metabolism and epigenetics. Protein & Cell. PMID 32356279 DOI: 10.1007/S13238-020-00722-W  1
2020 Prescott NA, David Y. In Vivo Histone Labeling Using Ultrafast trans-Splicing Inteins. Methods in Molecular Biology (Clifton, N.J.). 2133: 201-219. PMID 32144669 DOI: 10.1007/978-1-0716-0434-2_10  1
2019 Zheng Q, Maksimovic I, Upad A, Guber D, David Y. Synthesis of an Alkynyl Methylglyoxal Probe to Investigate Non-enzymatic Histone Glycation. The Journal of Organic Chemistry. PMID 31875401 DOI: 10.1021/Acs.Joc.9B02504  1
2019 Yusufova N, Teater MR, Soshnev A, Kloetgen A, Osunsade A, Conway J, Doane A, Skoultchi A, Tsirigos A, David Y, Allis CD, Cesarman E, Melnick A. Histone 1 Mutations Drive Lymphomagenesis By Inducing Primitive Stem Cell Functions and Epigenetic Instructions through Profound 3D Re-Organization of the B-Cell Genome. Blood. 134: 23. PMID 31723979 DOI: 10.1182/Blood-2019-127774  1
2019 Maksimovic I, Ray D, Zheng Q, David Y. Utilizing intein trans-splicing for in vivo generation of site-specifically modified proteins. Methods in Enzymology. 626: 203-222. PMID 31606075 DOI: 10.1016/Bs.Mie.2019.07.015  1
2019 Prescott NA, Bram Y, Schwartz RE, David Y. Targeting Hepatitis B Virus cccDNA and HBx: Recent Advances and New Approaches. Acs Infectious Diseases. PMID 31525994 DOI: 10.1021/Acsinfecdis.9B00249  1
2019 Zheng Q, Omans ND, Leicher R, Osunsade A, Agustinus AS, Finkin-Groner E, D'Ambrosio H, Liu B, Chandarlapaty S, Liu S, David Y. Reversible histone glycation is associated with disease-related changes in chromatin architecture. Nature Communications. 10: 1289. PMID 30894531 DOI: 10.1038/S41467-019-09192-Z  1
2019 Zheng Q, Prescott NA, Maksimovic I, David Y. (de)Toxifying the Epigenetic Code. Chemical Research in Toxicology. PMID 30839196 DOI: 10.1021/Acs.Chemrestox.9B00013  1
2018 Osunsade A, Prescott NA, Hebert JM, Ray DM, Jmeian Y, Lorenz IC, David Y. A Robust Method for the Purification and Characterization of Recombinant Human Histone H1 Variants. Biochemistry. PMID 30585724 DOI: 10.1021/Acs.Biochem.8B01060  1
2017 Oslund RC, Su X, Haugbro M, Kee JM, Esposito M, David Y, Wang B, Ge E, Perlman DH, Kang Y, Muir TW, Rabinowitz JD. Bisphosphoglycerate mutase controls serine pathway flux via 3-phosphoglycerate. Nature Chemical Biology. PMID 28805803 DOI: 10.1038/Nchembio.2453  1
2017 David Y, Muir TW. Emerging chemistry strategies for engineering native chromatin. Journal of the American Chemical Society. PMID 28635271 DOI: 10.1021/Jacs.7B03430  1
2017 Liszczak GP, Brown ZZ, Kim SH, Oslund RC, David Y, Muir TW. Genomic targeting of epigenetic probes using a chemically tailored Cas9 system. Proceedings of the National Academy of Sciences of the United States of America. PMID 28069948 DOI: 10.1073/Pnas.1615723114  1
2015 Holt MT, David Y, Pollock S, Tang Z, Jeon J, Kim J, Roeder RG, Muir TW. Identification of a functional hotspot on ubiquitin required for stimulation of methyltransferase activity on chromatin. Proceedings of the National Academy of Sciences of the United States of America. PMID 26240340 DOI: 10.1073/Pnas.1504483112  1
2015 David Y, Vila-Perelló M, Verma S, Muir TW. Chemical tagging and customizing of cellular chromatin states using ultrafast trans-splicing inteins. Nature Chemistry. 7: 394-402. PMID 25901817 DOI: 10.1038/Nchem.2224  1
2015 Altun M, Walter TS, Kramer HB, Herr P, Iphöfer A, Boström J, David Y, Komsany A, Ternette N, Navon A, Stuart DI, Ren J, Kessler BM. The human otubain2-ubiquitin structure provides insights into the cleavage specificity of poly-ubiquitin-linkages. Plos One. 10: e0115344. PMID 25590432 DOI: 10.1371/Journal.Pone.0115344  1
2015 Altun M, Walter TS, Kramer HB, Herr P, Iphöfer A, Boström J, David Y, Komsany A, Ternette N, Navon A, Stuart DI, Ren J, Kessler BM. OTUB2 has a broader cleavage profile than OTUB1. Plos One. DOI: 10.1371/Journal.Pone.0115344.G005  1
2014 Nguyen UT, Bittova L, Müller MM, Fierz B, David Y, Houck-Loomis B, Feng V, Dann GP, Muir TW. Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries. Nature Methods. 11: 834-40. PMID 24997861 DOI: 10.1038/Nmeth.3022  1
2014 Berko D, Herkon O, Braunstein I, Isakov E, David Y, Ziv T, Navon A, Stanhill A. Inherent asymmetry in the 26S proteasome is defined by the ubiquitin receptor RPN13. The Journal of Biological Chemistry. 289: 5609-18. PMID 24429290 DOI: 10.1074/Jbc.M113.509380  1
2012 Pomerantz Y, Elbaz J, Ben-Eliezer I, Reizel Y, David Y, Galiani D, Nevo N, Navon A, Dekel N. From ubiquitin-proteasomal degradation to CDK1 inactivation: requirements for the first polar body extrusion in mouse oocytes. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 4495-505. PMID 22859367 DOI: 10.1096/Fj.12-209866  1
2011 David Y, Ternette N, Edelmann MJ, Ziv T, Gayer B, Sertchook R, Dadon Y, Kessler BM, Navon A. E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes. The Journal of Biological Chemistry. 286: 44104-15. PMID 21965653 DOI: 10.1074/Jbc.M111.234559  1
2011 Shimshon L, Michaeli A, Hadar R, Nutt SL, David Y, Navon A, Waisman A, Tirosh B. SUMOylation of Blimp-1 promotes its proteasomal degradation. Febs Letters. 585: 2405-9. PMID 21722636 DOI: 10.1016/J.Febslet.2011.06.022  1
2010 David Y, Ziv T, Admon A, Navon A. The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines. The Journal of Biological Chemistry. 285: 8595-604. PMID 20061386 DOI: 10.1074/Jbc.M109.089003  1
Show low-probability matches.